Andrew D. Ashe does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verve Therapeutics, Inc., APPLIED GENETIC TECHNOLOGIES CORP, and DYAX CORP.

2016 was Andrew D. Ashe's most active year for acquiring shares with 8 total transactions. Andrew D. Ashe's most active month to acquire stocks was the month of July. 2016 was Andrew D. Ashe's most active year for disposing of shares, totalling 16 transactions. Andrew D. Ashe's most active month to dispose stocks was the month of December. 2016 saw Andrew D. Ashe paying a total of $2,106,437.29 for 297,401 shares, this is the most they've acquired in one year. In 2015 Andrew D. Ashe cashed out on 128,540 shares for a total of $1,569,220.25, their largest year based on trade value.